Abstract

BackgroundData about different types of cardiac biomarkers is still limited in children with congenital heart disease (CHD) when compared to that in adults. We evaluated the circulating levels of B-type natriuretic peptide (BNP) in children with different types of CHD and correlated the levels with the calculated Qp/Qs ratio and the outcome of the congenital heart surgery. MethodsA prospective cross sectional- case control study was carried out on 43 pediatric patients with different types of CHD, undergoing elective cardiac surgery for shunt closure, admitted at the department of Cardiothoracic surgery-Faculty of Medicine- Assiut and Qena University hospitals. This was in addition to 17 healthy controls. All patients were diagnosed by echocardiography and cardiac catheterization. Qp/Qs ratio was calculated for every included patient. ELISA assays of plasma levels of BNP in the study groups were done. ResultsThe following findings were obtained: significant higher plasma levels of BNP among CHD children when compared with the control group (p < 0.001). Significant higher Qp/Qs ratio in children having ASD or VSD versus those had PDA (p < 0.001). Significant positive correlation between plasma BNP and Qp/Qs ratio among CHD children (r = 0.541, p < 0.001). Cut-off values for plasma BNP and Qp/Qs ratio in predicting the negative outcome were >55 pg/ml and >2.36 respectively with 100% sensitivity and 97.5% specificity. ConclusionsBNP could be considered as a valuable cardiac marker in CHD and could be a reliable marker for predicting the negative outcome of the congenital heart surgery when combined with Qp/Qs ratio.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call